Private Market View

Vivace Therapeutics

Drug Discovery · San Mateo, CA · Founded 2014 · Privately Held (backing)

Last price · $/share
Implied valuation
$125.0M
Total raised
$105.0M
Last round
Later Stage VC (Series D)
Feb 2025
How much has Vivace Therapeutics raised?
$105.0Macross 4 recorded rounds · Jan 2015Feb 2025

Most recently, Vivace Therapeutics raised $35.0M in its Later Stage VC (Series D) (Feb 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 4 rounds
  • ·The complete investor list — 11 names
  • ·Watchlist + deal alerts for Vivace Therapeutics
Create free account
No card required

Round by round

4 rounds
Feb 2025Later Stage VC (Series D)$35.0M
+ 1 more investors · free account
Dec 2020Early Stage VC$30.0MSEC filing
6 investors participated
May 2017Early Stage VC$8.0MSEC filing
6 investors participated
Jan 2015Early Stage VC$5.0MSEC filing
3 investors participated
For fundraisers
Raising for a company like Vivace Therapeutics?

11 investors have backed Vivace Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 11 investors →

Frequently asked

How much has Vivace Therapeutics raised?
Vivace Therapeutics has raised $105.0M in total across 4 recorded funding rounds.
When was Vivace Therapeutics's last funding round?
Vivace Therapeutics's most recent recorded round was Later Stage VC (Series D) in Feb 2025, raising $35.0M.